Financial Daily from THE HINDU group of publications
Thursday, Jun 16, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Overseas Borrowings


Orchid Chemicals plans $100 m GDR issue

Our Bureau

Chennai , June 15

ORCHID Chemicals & Pharmaceuticals proposes to raise $100 million through an issue of Global Depository Receipts.

The company had earlier planned a `foreign currency convertible bond' issue for $75 million, but has now decided in favour of a GDR issue.

A spokesman of Orchid Chemicals told Business Line today that the company preferred raising funds through equity than debt, because it might then get better valuations.

The spokesman said that the funds could come into the company in "a couple of months".

He said that part of the funds would be used for retiring some of the relatively high cost debt and the other part for getting into multi-therapeutic areas — non-anti-biotic drugs such as anti-diabetes.

"The physical infrastructure for producing them is already in place," the spokesman pointed out.

Orchid's associate company, Bexel Pharmaceuticals of the US, is the assignee of the intellectual property for the anti-diabetic molecule's (BLX-1002) discovery. The molecule has cleared Phase 2(a) clinical trials, which covers a limited proof-of-concept.

In addition to the GDR issue, Orchid Chemicals intends to issue 25 lakh warrants to the promoters, which are convertible into equity. An employee stock option plan is also on the cards.

To accommodate the GDR, convertible warrants and employees' options, the authorised capital of the company is sought to be raised to Rs 55 crore from Rs 45 crore now.

The annual general meeting of the company is to be held on July 18.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
HM in talks with Volkswagen, Peugeot for component supplies


Skoda to roll out 4 new models; plans exports
No plans to sell stake, says Gillette India promoter
IOC to introduce branded diesel for fishing sector
Callidai Motor launches 4 new products
RPG Life Sciences closes Pune unit
HML board clears Erumely rubber estate sale
Adani bags contract to build silos for FCI
Orchid Chemicals plans $100 m GDR issue
India Inc wants Clause 49 deadline extended
Emerson stepping up recruitment in Pune
J.J. Exporters to merge 2 subsidiaries with it
Philips India set to complete merger by July-end — New company to be named Philips Electronics India
Posco may ink Orissa deal on June 22
DCM Shriram to expand sugar, chlor alkali capacities
MSP Steel plans to raise Rs 16 cr thru public issue
Time frame set for grant of disclosure approvals
Tata Investment bonus issue
Bosch may bring CRDi systems to India — Sees big demand from car segment


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line